{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:49:26Z","timestamp":1782730166647,"version":"3.54.5"},"reference-count":22,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019573","name":"Amsterdam University Medical Centers","doi-asserted-by":"publisher","award":["Innovation grant"],"award-info":[{"award-number":["Innovation grant"]}],"id":[{"id":"10.13039\/100019573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"\n Objective<\/jats:title>\n To examine inpatient benzodiazepine receptor agonists prescribing patterns and assess how hospitalisation affects use at discharge.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Subanalysis of the WEsleep trial, a cluster-randomised controlled single-centre study conducted at Amsterdam University Medical Center (Amsterdam UMC) (two locations) between July 2023 and March 2024. Twelve departments (six medical, six surgical) were matched and randomised to intervention or standard care. On intervention wards, multiple measures to improve sleep were implemented, including minimising nighttime disruptions.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Amsterdam UMC, across medical and surgical hospital departments.<\/jats:p>\n <\/jats:sec>\n \n Patients<\/jats:title>\n Adult patients admitted for \u22652 nights (medical) or undergoing elective non-cardiac surgery in a surgical department.<\/jats:p>\n <\/jats:sec>\n \n Primary and secondary outcome measures<\/jats:title>\n Benzodiazepine use was classified as no use, pre-admission use or new in-hospital initiation. Prescribing patterns were summarised descriptively according to type, timing, indication and discharge status.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 746 patients, 187 (25%) used benzodiazepines: 80 (43%) had pre-admission use, and 107 (57%) were newly initiated during their hospital stay. Among pre-admission users, two discontinued and five had adjustments at discharge. Among newly initiated users, 94 (88%) had their benzodiazepine discontinued at discharge. Approximately half of pre-admission prescriptions and one-third of in-hospital prescriptions lacked a documented indication.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Although most newly initiated benzodiazepine treatments were discontinued during hospitalisation, pre-existing use was rarely reassessed and nearly 10% of new users were discharged with a prescription. Structured deprescribing protocols, better documentation of indications and improved discharge planning are needed to promote safer and more rational benzodiazepine use.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n NCT05683483<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-112758","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:11:09Z","timestamp":1771326669000},"page":"e112758","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Benzodiazepine receptor agonists in hospitalised patients in the Netherlands: initiation, continuation and discontinuation \u2013 a retrospective observational analysis"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct05683483","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05683483","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-9539","authenticated-orcid":false,"given":"Carlijn J","family":"de Gans","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section General Internal Medicine unit Acute Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands"},{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva S","family":"van den Ende","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section General Internal Medicine unit Acute Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands"},{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen J G","family":"Meewisse","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"van Zuylen","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Pediatric Intensive Care, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk Jan","family":"Stenvers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, The Netherlands"},{"name":"Amsterdam Gastroenterology Endocrinology and Metabolism (AGEM), Amsterdam University Medical center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hermanides","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-3682","authenticated-orcid":false,"given":"Prabath W B","family":"Nanayakkara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section General Internal Medicine unit Acute Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands"},{"name":"Amsterdam Public Health Research Institute, Quality of Care, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026062610405302000_16.2.e112758.1","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"2026062610405302000_16.2.e112758.2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90044-N"},{"key":"2026062610405302000_16.2.e112758.3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pharma.2009.07.001","article-title":"Benzodiazepine dependence: focus on withdrawal syndrome","volume":"67","author":"Authier","year":"2009","journal-title":"Ann Pharm Fr"},{"key":"2026062610405302000_16.2.e112758.4","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921020-00004"},{"key":"2026062610405302000_16.2.e112758.5","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13040059"},{"key":"2026062610405302000_16.2.e112758.6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L062"},{"key":"2026062610405302000_16.2.e112758.7","unstructured":"Nationale Drug Monitor . Gebruik: volwassenen. In: Slaap- en kalmeringsmiddelen. 2025. Available: https:\/\/www.nationaledrugmonitor.nl\/slaapenkalmeringsmiddelen-gebruik-algemene-bevolking\/"},{"key":"2026062610405302000_16.2.e112758.8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026062610405302000_16.2.e112758.9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jamainternmed.2018.2669","article-title":"Quality and Quantity of Sleep and Factors Associated With Sleep Disturbance in Hospitalized Patients","volume":"178","author":"Wesselius","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2026062610405302000_16.2.e112758.10","first-page":"100059","article-title":"Sleep in hospitalized pediatric and adult patients \u2013 A systematic review and meta-analysis","volume":"4","author":"Burger","year":"2022","journal-title":"Sleep Medicine: X"},{"key":"2026062610405302000_16.2.e112758.11","doi-asserted-by":"crossref","unstructured":"Geensen R , Verhoeven JG , Hendriks JM , et al . Prevalence and Incidence of Oral Benzodiazepine Use in Hospitalized Surgical Patients: A Retrospective Cohort Study. Ann Surg 2025. doi:10.1097\/SLA.0000000000006647","DOI":"10.1097\/SLA.0000000000006647"},{"key":"2026062610405302000_16.2.e112758.12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/pds.621","article-title":"Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates","volume":"10","author":"Lagnaoui","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026062610405302000_16.2.e112758.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066234","article-title":"Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study","volume":"13","author":"Keller","year":"2023","journal-title":"BMJ Open"},{"key":"2026062610405302000_16.2.e112758.14","doi-asserted-by":"crossref","first-page":"106308","DOI":"10.1016\/j.ejim.2025.04.015","article-title":"The effects of sleep improving interventions in medical hospital wards: the WEsleep study - A randomized clinical trial","volume":"139","author":"de Gans","year":"2025","journal-title":"Eur J Intern Med"},{"key":"2026062610405302000_16.2.e112758.15","doi-asserted-by":"crossref","unstructured":"Grimmsmann T , Harden M , Fi\u00df T , et al . n.d. The influence of hospitalisation on the initiation, continuation and discontinuation of benzodiazepines and Z-drugs \u2013 an observational study. Swiss Med Wkly 148:w14590. doi:10.4414\/smw.2018.14590","DOI":"10.4414\/smw.2018.14590"},{"key":"2026062610405302000_16.2.e112758.16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/pds.4806","article-title":"Patient-reported factors associated with the desire to continue taking sleep-inducing drugs after hospital discharge: A survey of older adults","volume":"28","author":"Heinemann","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026062610405302000_16.2.e112758.17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy844"},{"key":"2026062610405302000_16.2.e112758.18","doi-asserted-by":"crossref","unstructured":"Arnold I , Straube K , Himmel W , et al . High prevalence of prescription of psychotropic drugs for older patients in a general hospital. BMC Pharmacol Toxicol 2017;18. doi:10.1186\/s40360-017-0183-0","DOI":"10.1186\/s40360-017-0183-0"},{"key":"2026062610405302000_16.2.e112758.19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/bcpt.13811","article-title":"Use of benzodiazepines and benzodiazepine\u2010related drugs in the Nordic countries between 2000 and 2020","volume":"132","author":"H\u00f8jlund","year":"2023","journal-title":"Basic Clin Pharma Tox"},{"key":"2026062610405302000_16.2.e112758.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2011.03.006"},{"key":"2026062610405302000_16.2.e112758.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000245705.69440.6a"},{"key":"2026062610405302000_16.2.e112758.22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.sleh.2022.07.004","article-title":"Gender differences in the prevalence of and trends in sleep patterns and prescription medications for insomnia among US adults, 2005 to 2018","volume":"8","author":"Zuo","year":"2022","journal-title":"Sleep Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-112758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:38:06Z","timestamp":1782729486000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-112758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-112758"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-112758","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}